Detalhe da pesquisa
1.
Value-based pricing of cognitive behavioral therapy for depression in primary care: an economic evaluation.
BMC Health Serv Res
; 24(1): 317, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459545
2.
Long COVID: Costs for the German economy and health care and pension system.
BMC Health Serv Res
; 23(1): 641, 2023 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316880
3.
Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer's perspective.
BMC Health Serv Res
; 22(1): 47, 2022 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000587
4.
COVID-19 and the forgone health benefits of elective operations.
BMC Health Serv Res
; 22(1): 1545, 2022 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528629
5.
Was EU's COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations.
BMC Health Serv Res
; 22(1): 1410, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434631
6.
Value-based pricing of a COVID-19 vaccine.
Q Rev Econ Finance
; 84: 1-8, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975265
7.
The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany.
Q Rev Econ Finance
; 84: 502-509, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33071532
8.
A parsimonious model to validate cost-effectiveness analyses on preventive health care.
BMC Health Serv Res
; 21(1): 1213, 2021 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753466
9.
The price of curing cancer.
BMC Health Serv Res
; 21(1): 1328, 2021 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895213
10.
Autonomy, Coercion, and Public Healthcare Guarantees: The Uptake of Sofosbuvir in Germany.
Camb Q Healthc Ethics
; 30(1): 90-102, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33371914
11.
A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency.
BMC Health Serv Res
; 20(1): 240, 2020 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293433
12.
Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG.
BMC Health Serv Res
; 20(1): 343, 2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321496
13.
Negative Drug Pricing in the Context of Cost-Effectiveness Analysis: A Consistency Examination.
Value Health
; 27(1): 131, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816455
14.
Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy.
Health Econ
; 28(1): 101-122, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306669
15.
Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases.
Value Health
; 21(5): 525-531, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29753348
16.
Vaccination Mandates, Physically Forced Vaccination, and Rationing in the Intensive Care Unit: Searching for Ethical Coherence in the COVID-19 Pandemic.
Am J Bioeth
; 22(11): 11-14, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35225748
17.
Strategy for the "New Normal" of Life With COVID.
JAMA
; 327(18): 1823-1824, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536269
18.
Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation.
Health Econ
; 25(2): 249-56, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25684073
19.
Defining Comparators According to IQWiG's Efficiency-Frontier Method.
Value Health
; 23(5): 674-675, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389234
20.
Drug pricing and control of health expenditures: a comparison between a proportional decision rule and a cost-per-QALY rule.
Int J Health Plann Manage
; 30(4): 395-402, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24789123